China-Biotics, Inc. ("China-Biotics", the "Company") (NASDAQ: CHBT), the leading developer, manufacturer and distributor of probiotics products in China, announced it has applied for 5 new patents through its wholly owned subsidiary Growing Bioengineering to the State Bureau of Intellectual Property. These patent applications are related to new products and preparation methods under development for baby care, daily health and beauty product, female hygiene, and soy milk markets.
A patent has been filed for a new probiotics supplement and its preparation, to strengthen babies' immune and digestive systems to reduce diarrhea, a frequent condition for small children. A second patent is for micro-capsulation technique used to create probiotics used in daily health and beauty products. Another patent has been filed for probiotics to be used in female hygiene products. A patent for the preparation of and for the probiotics to be added to soy milk has been filed. The final patent is for the manufacturing methods and uses of the Company's technology for a heat-resistant micro-encapsulated probiotics.
When introduced, these products will be China-Biotics' first entry into these new markets, which have large growth potential and recurring purchase tendencies.
Mr. Jinan Song, Chairman and CEO of China-Biotics, commented, "As we successfully ramp up the utilization rate of our Qingpu facility, our research and development team are proactively developing more and more new applications for probiotics to meet the needs of an ever growing Chinese consumer base. The benefits of probiotics are becoming increasingly acknowledged by a more health-aware population. We are confident that our efforts in introducing innovative products for new markets will augment our growth in the future and broaden probiotics usage."
China-Biotics, Inc. ("China-Biotics" or "the Company"), a leading manufacturer of biotechnology products and supplements, engages in the research, development, marketing and distribution of probiotics dietary supplements in China. Through its wholly owned subsidiaries, Shanghai Shining Biotechnology Co., Ltd. and Growing Bioengineering (Shanghai) Co. Ltd., the Company develops and produces a proprietary product portfolio. Currently, its retail products are sold over the counter, mainly through large distributors, to pharmacies and supermarkets in Beijing, Shanghai, and Jiangsu and Zhejiang provinces. The Company also sells bulk products to institutional customers such as dairy and animal feed producers as well as pharmaceutical companies. In February 2010, China-Biotics began its commercial production in China's largest probiotics production facility to meet the growing demand in China. For more information, please visit http://www.chn-biotics.com.